Mites (Acari, Acariformes, Parasitiformes) are one of the most diverse and abundant groups of arthropods associated with birds. Several families of mites have colonised the respiratory tract of birds, the Rhinonyssidae (Mesostigmata) being the most diverse. There are 66 species of rhinonyssids (59 named, seven undescribed species) reported from Canadian birds. Two new species of rhinonyssids were discovered while surveying nasal mites from birds in Manitoba, Canada, and are herein described as from the horned lark (), and from the common nighthawk ().
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168614 | PMC |
| http://dx.doi.org/10.3897/zookeys.786.28767 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CMPK2 promotes NLRP3 inflammasome activation via mtDNA-STING pathway in house dust mite-induced allergic rhinitis.
Clin Transl Med
January 2025
Allergy Center, Department of Otolaryngology, Affiliated Eye and ENT Hospital, Fudan University, Shanghai, China.
Background: House dust mite (HDM) is the leading allergen for allergic rhinitis (AR). Although allergic sensitisation by inhaled allergens renders susceptible individuals prone to developing AR, the molecular mechanisms driving this process remain incompletely elucidated.
Objective: This study aimed to elucidate the molecular mechanisms underlying HDM-induced AR.
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan.
Allergy Asthma Proc
January 2025
Department of Pharmacovigilance, Pharmacovigilance and Quality Assurance Group, Torii Pharmaceutical Co., Ltd., Tokyo, Japan.
Standardized quality (SQ) house-dust mite (HDM) sublingual immunotherapy tablets (10,000 Japanese allergy units [JAU], equivalent to 6 SQ-HDM in Europe and the United States) are licensed for the treatment of HDM-induced allergic rhinitis (AR) without age restriction, based on 52-week administration clinical trials. There are no large-scale data on the administration of 10,000 JAU for > 1 year in actual clinical practice. To examine the safety and effectiveness of 10,000 JAU during use for up to 3 years at real-world clinical sites in Japan.
View Article and Find Full Text PDFAssociation between allergen-specific immunoglobulin E sensitization, allergic rhinitis symptoms, and quality of life in school-aged children.
Sci Rep
December 2024
Department of Epidemiology and Environmental Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
This study aimed to investigate the relationship between allergen-specific immunoglobulin E (IgE) sensitization and allergic rhinitis (AR) symptoms in school-aged children in Japan and to understand the current severity of AR symptoms and the quality of life (QOL) among children with AR. We analyzed data from 8-year-old children who participated in the Yamanashi Adjunct Study of the Japan Environment and Children's Study, focusing on those with complete information on specific IgE levels and AR (1229 for perennial AR [PAR] and 1196 for seasonal AR [SAR]). Sensitization was determined when allergen-specific IgE levels were class 2 (0.
View Article and Find Full Text PDFReevaluating the Causes of Otitis Externa: A Case Report.
Cureus
November 2024
Department of Otorhinolaryngology, Woodlands Health Campus, Singapore, SGP.
A 28-year-old female domestic helper presented to the Ear, Nose, and Throat clinic complaining of three weeks of right otalgia associated with a right blocked ear. The hearing was otherwise normal, and she denied otorrhoea, dizziness or imbalance, ear digging, or water contact, and has no history of ear eczema. She has no other past medical history and no recent travel history.
View Article and Find Full Text PDFEpithelial-Mesenchymal Transition in Chronic Rhinosinusitis.
J Rhinol
July 2024
Department of Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea.
Chronic rhinosinusitis (CRS) is characterized by prolonged inflammation of the nasal and paranasal sinus mucosa lasting over 12 weeks. CRS is divided into two main types based on the presence of nasal polyps: CRS without nasal polyps and CRS with nasal polyps. The condition is further classified into endotypes based on type 1, type 2, and type 3 inflammatory signatures, with differences in terms of disease severity, prognosis, and treatment response.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!